1
Dan Peters, Gunnar M Olsen, Elsebet Østergaard Nielsen, Philip K Ahring, Tino Dyhring Jørgensen: 3-substituted quinuclidines and their use as nicotinic agonists. Neurosearch, Birch Stewart Kolasch & Birch, April 26, 2005: US06884807

This invention relates to novel 3-substituted quinuclidine derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for ...


2
Peters Dan, Olsen Gunnar M, Nielsen Elsebet Stergaard, Ahring Philip K, Jurgensen Tino Dyhring: 3-substituted quinuclidines and their use as nicotinic agonists. Neurosearch, September 3, 2003: EP1339712-A1

This invention relates to novel 3-substituted quinuclidine derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for ...


3
Dan Peters, Gunnar M Olsen, Elsebet Ostergaard Nielsen, Philip K Ahring, Tino Dyhring Jorgensen: 3-Substituted quinuclidines and their use as nicotinic agonists. Birch Stewart Kolasch & Birch, March 4, 2004: US20040044026-A1

This invention relates to novel 3-substituted quinuclidine derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for ...


4
Peters Dan, Olsen Gunnar M, Nielsen Elsebet Østergaard, Ahring Philip K, Jørgensen Tino Dyhring: 3-substituted quinuclidines and their use as nicotinic agonists. Neurosearch, Peters Dan, Olsen Gunnar M, Nielsen Elsebet Østergaard, Ahring Philip K, Jørgensen Tino Dyhring, NEUROSEARCH, June 6, 2002: WO/2002/044176

This invention relates to novel 3-substituted quinuclidine derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for ...